home
docs

Middle East, North Africa, Afghanistan & Pakistan (excluding high income) Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV) 2026: Interactive Chart & Historical Data

Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV) in Middle East, North Africa, Afghanistan & Pakistan (excluding high income) stood at 20.05% in 2024, according to World Bank. The latest value is up 4.03 percentage points from 16.02% in 2023. Ten years earlier, in 2014, the value was 13.74% (up 6.31 percentage points since). The highest value since 2000 was 24.59% in 2019, the lowest 0% in 2000.

Data source: World Bank · Unit: % · Category: Healthcare · Explore more indicators on EconDash

Data updated:Last checked:Frequency:AnnualCoverage:2000–2024

Key facts

What is the latest Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV) in Middle East, North Africa, Afghanistan & Pakistan (excluding high income)?

Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV) in Middle East, North Africa, Afghanistan & Pakistan (excluding high income) stood at 20.05% in 2024, according to World Bank.

Is Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV) in Middle East, North Africa, Afghanistan & Pakistan (excluding high income) rising or falling?

The latest value is up 4.03 percentage points from 16.02% in 2023. Ten years earlier, in 2014, the value was 13.74% (up 6.31 percentage points since).

What is the highest Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV) on record in Middle East, North Africa, Afghanistan & Pakistan (excluding high income)?

The highest value since 2000 was 24.59% in 2019, the lowest 0% in 2000.

Metadata for Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV) in Middle East, North Africa, Afghanistan & Pakistan (excluding high income)
IndicatorAntiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)
CountryMiddle East, North Africa, Afghanistan & Pakistan (excluding high income)
CategoryHealthcare
Unit%
SourceWorld Bank
Interactive chartView on EconDash
API accessEconDash API documentation

Latest value: 20.05% (2024)

Loading chart...

Source:World Bank — series SH.HIV.PMTC.ZS
License:CC BY 4.0
Cite this chart
APA

World Bank. (2026). Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV) — Middle East, North Africa, Afghanistan & Pakistan (excluding high income) [Data set]. Retrieved November 13, 2026, from EconDash: https://econdash.org/chart/wdi-sh-hiv-pmtc-zs/MNA. Original source: https://data.worldbank.org/indicator/SH.HIV.PMTC.ZS

MLA

World Bank. "Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV) — Middle East, North Africa, Afghanistan & Pakistan (excluding high income)." EconDash, 2026, https://econdash.org/chart/wdi-sh-hiv-pmtc-zs/MNA. Accessed 13 Nov. 2026. Original source: https://data.worldbank.org/indicator/SH.HIV.PMTC.ZS.

Chicago

World Bank. 2026. "Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV) — Middle East, North Africa, Afghanistan & Pakistan (excluding high income)." EconDash. Accessed November 13, 2026. https://econdash.org/chart/wdi-sh-hiv-pmtc-zs/MNA. Original source: https://data.worldbank.org/indicator/SH.HIV.PMTC.ZS.

BibTeX
@misc{econdash_wdi_sh_hiv_pmtc_zs_mna,
  author = {{World Bank}},
  title = {{Antiretroviral therapy coverage for PMTCT (\% of pregnant women living with HIV) --- Middle East, North Africa, Afghanistan \& Pakistan (excluding high income)}},
  howpublished = {EconDash},
  year = {2026},
  url = {https://econdash.org/chart/wdi-sh-hiv-pmtc-zs/MNA},
  note = {Accessed: 2026-11-13. Original source: https://data.worldbank.org/indicator/SH.HIV.PMTC.ZS}
}